5.69
-0.03
(-0.52%)
At close: April 17 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 45.67M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Percario (Monica Barbanti Cabral de Vasconcellos) Senior Officer of Issuer | Exercise of rights at price 4.31 per share. | Direct | 23,360 | Apr 1, 2025 |
Sakhia, Samira Director of Issuer | Exercise of rights at price 4.31 per share. | Direct | 225,893 | Apr 1, 2025 |
Utchanah (Arvind) Senior Officer of Issuer | Exercise of rights at price 4.31 per share. | Direct | 85,706 | Apr 1, 2025 |
Bosano (Leopoldo Agustin) Senior Officer of Issuer | Exercise of rights at price 4.31 per share. | Direct | 27,160 | Apr 1, 2025 |
Cristiane (Zanqueta Coelho Peev) Senior Officer of Issuer | Exercise of rights at price 4.31 per share. | Direct | 21,302 | Apr 1, 2025 |
Dos Santos Dias (Henrique Jose) Senior Officer of Issuer | Exercise of rights at price 4.31 per share. | Direct | 16,682 | Apr 1, 2025 |
Emblem (Susan Caroline) Senior Officer of Issuer | Exercise of rights at price 4.31 per share. | Direct | 21,988 | Apr 1, 2025 |
Goodman (Jonathan Ross) Director of Issuer | Exercise of rights at price 4.31 per share. | Direct | 83,838 | Apr 1, 2025 |
Groleau (Melanie) Senior Officer of Issuer | Exercise of rights at price 4.31 per share. | Direct | 11,867 | Apr 1, 2025 |
Khouri, Amal Senior Officer of Issuer | Exercise of rights at price 4.31 per share. | Direct | 46,517 | Apr 1, 2025 |
Knight Therapeutics, Inc. Issuer | -- | Direct | -- | Mar 31, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.39 per share. | Indirect | 10,977,500 | Mar 21, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.44 per share. | Indirect | 340,027 | Mar 20, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.47 per share. | Indirect | 223,400 | Mar 20, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.36 per share. | Indirect | 21,815 | Mar 19, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.33 per share. | Indirect | 3,246,000 | Mar 19, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.33 per share. | Indirect | 2,380,400 | Mar 19, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.37 per share. | Indirect | 23,166 | Mar 18, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.30 per share. | Indirect | 396,828 | Mar 17, 2025 |
Dos Santos Dias (Henrique Jose) Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 4.16 per share. | Direct | 2,126 | Mar 15, 2025 |
Emblem (Susan Caroline) Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 4.16 per share. | Direct | 4,582 | Mar 15, 2025 |
Emblem (Susan Caroline) Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 3.51 per share. | Direct | 1,045 | Mar 15, 2025 |
Goodman (Jonathan Ross) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 4.16 per share. | Direct | 3,491 | Mar 15, 2025 |
Goodman (Jonathan Ross) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 3.51 per share. | Direct | 722 | Mar 15, 2025 |
Khouri, Amal Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 4.16 per share. | Direct | 3,966 | Mar 15, 2025 |
Khouri, Amal Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 3.51 per share. | Direct | 1,547 | Mar 15, 2025 |
Lopez (German) Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 4.16 per share. | Direct | 4,482 | Mar 15, 2025 |
Sakhia, Samira Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 4.16 per share. | Direct | 9,406 | Mar 15, 2025 |
Sakhia, Samira Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 3.51 per share. | Direct | 1,946 | Mar 15, 2025 |
Utchanah (Arvind) Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 4.16 per share. | Direct | 4,295 | Mar 15, 2025 |
Utchanah (Arvind) Senior Officer of Issuer | Acquisition or disposition under a purchase/ownership plan at price 3.51 per share. | Direct | 838 | Mar 15, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.18 per share. | Indirect | 2,923,200 | Mar 14, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.22 per share. | Indirect | 4,647 | Mar 13, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.25 per share. | Indirect | 395,196 | Mar 12, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.28 per share. | Indirect | 33,384 | Mar 12, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 3.98 per share. | Indirect | 70,118 | Mar 11, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 4.26 per share. | Indirect | 426,100 | Mar 11, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.80 per share. | Direct | 33,060 | Mar 10, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.84 per share. | Direct | 64,444 | Mar 7, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.91 per share. | Direct | 56,246 | Mar 6, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.90 per share. | Direct | 28,506 | Mar 5, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.86 per share. | Direct | 64,848 | Mar 4, 2025 |
Armoyan (Sime) 10% Security Holder of Issuer | Acquisition or disposition in the public market at price 3.81 per share. | Indirect | 67,056 | Mar 4, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.80 per share. | Direct | 58,566 | Mar 3, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.80 per share. | Direct | 46,396 | Feb 28, 2025 |
Knight Therapeutics, Inc. Issuer | -- | Direct | -- | Feb 28, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.84 per share. | Direct | 64,596 | Feb 27, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.87 per share. | Direct | 64,982 | Feb 26, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.88 per share. | Direct | 51,657 | Feb 25, 2025 |
Knight Therapeutics, Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.94 per share. | Direct | 40,540 | Feb 24, 2025 |
Related Tickers
HLS.TO HLS Therapeutics Inc.
4.2000
-1.18%
CTX.TO Crescita Therapeutics Inc.
0.5900
0.00%
OPTN OptiNose, Inc.
9.17
+0.11%
INDV Indivior PLC
9.01
-0.55%
BHC.TO Bausch Health Companies Inc.
7.07
+13.30%
MRKC.F Merck KGaA
23.20
+0.87%
MRKC.SG Merck KGaA
22.80
-0.87%
MRKC.DU Merck KGaA
22.80
-0.87%
BON.F Boiron SA
23.55
-1.05%
R5XA.BE AcelRx Pharmaceuticals Inc
0.4175
-2.22%